TScan Therapeutics
(NASDAQ:TCRX)
$3.145
0.045[1.45%]
At close: Jun 30
$2.66
-0.4850[-15.42%]
After Hours: 9:09AM EDT
Day High/Low3.09 - 3.26
52 Week High/Low1.6 - 14.71
Open / Close3.13 / 3.15
Float / Outstanding16.3M / 24M
Vol / Avg.26.1K / 105.4K
Mkt Cap75.6M
P/E-
50d Avg. Price2.75
Div / Yield-
Payout Ratio-
EPS-0.67
Total Float16.3M

TScan Therapeutics (NASDAQ:TCRX), Quotes and News Summary

TScan Therapeutics (NASDAQ: TCRX)

Day High/Low3.09 - 3.26
52 Week High/Low1.6 - 14.71
Open / Close3.13 / 3.15
Float / Outstanding16.3M / 24M
Vol / Avg.26.1K / 105.4K
Mkt Cap75.6M
P/E-
50d Avg. Price2.75
Div / Yield-
Payout Ratio-
EPS-0.67
Total Float16.3M
Sector: Health Care.Industry: Biotechnology
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-18
REV
Q1 2022Est.ActualSurprise
EPS-0.670
REV3.021M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

TScan Therapeutics Questions & Answers

Q
How do I buy TScan Therapeutics (TCRX) stock?
A

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are TScan Therapeutics's (TCRX) competitors?
Q
What is the target price for TScan Therapeutics (TCRX) stock?
A

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by HC Wainwright & Co. on Tuesday, May 10, 2022. The analyst firm set a price target for 15.00 expecting TCRX to rise to within 12 months (a possible 376.95% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for TScan Therapeutics (TCRX)?
A

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $3.145 last updated June 30, 2022, 8:00 PM UTC.

Q
Does TScan Therapeutics (TCRX) pay a dividend?
A

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

Q
When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?
A

TScan Therapeutics’s Q2 earnings are confirmed for Thursday, August 18, 2022.

Q
Is TScan Therapeutics (TCRX) going to split?
A

There is no upcoming split for TScan Therapeutics.

Q
What sector and industry does TScan Therapeutics (TCRX) operate in?
A

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.